Sheetal Chini

<h3> Absolute Contraindications of Sheetal Chini </h3> <h4> Pregnancy / planning pregnancy [Avoid use during pregnancy]</h4> <ul> <li> 🤰 <li> Recommendation: Avoid consuming concentrated cubeb preparations (essential oils or high-dose extracts) during pregnancy; if a product contains concentrated essential oil constituents, do not use without an expert's approval. <li> Reasoning: Certain volatile constituents that occur in some Piper cubeba chemotypes (notably methyleugenol and related phenylpropanoids) have recognized genotoxic and carcinogenic potential in experimental systems; because fetal safety data are lacking and genotoxic agents are best avoided in pregnancy, caution is warranted. <li> Scientific_Study_Title: Aspartame, methyleugenol, and isoeugenol (IARC Monographs evaluation) <li> Scientific_Study_Authors: IARC Working Group on the Identification of Carcinogenic Hazards to Humans <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/39715313/ <li> Scientific_Study_Excerpt: <p>The IARC Working Group reviewed evidence on methyleugenol and related compounds and concluded that methyleugenol is probably carcinogenic to humans (Group 2A). The monograph summarises animal bioassays, mechanistic data and human exposure information showing methyleugenol forms DNA-reactive metabolites and DNA adducts after metabolic activation. The document explicitly highlights that methyleugenol occurs naturally in essential oils and spices, and because of its genotoxic mode of action the Working Group assigned the hazard classification. Based on this, routine use of products containing concentrated methyleugenol during pregnancy is not recommended because of uncertainty regarding fetal risk and absence of controlled safety data.</p> <p>Practical implication: avoid high-concentration essential-oil forms and consult a healthcare provider for low-dose traditional uses; prefer non-volatile formulations only under expert guidance.</p> </li> </ul> <h4> Severe liver disease / active hepatitis [Liver impairment]</h4> <ul> <li> 🧠🩺 (liver) <li> Recommendation: Do not use concentrated cubeb essential oil or large doses of extracts if you have active liver disease or markedly abnormal liver tests; consult a hepatologist first. <li> Reasoning: Experimental studies of methyleugenol (a constituent in some cubeb oils) show accumulation and dose-dependent hepatotoxic effects in animals, with raised liver enzymes and histologic changes; individuals with compromised hepatic clearance may be at increased risk. <li> Scientific_Study_Title: Hepatotoxicity Induced by Methyl Eugenol: Insights from Toxicokinetics, Metabolomics, and Gut Microbiota <li> Scientific_Study_Authors: Liang Chen, Jiaxin Li, Qian Li, Qingwen Sun <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/39451553/ <li> Scientific_Study_Excerpt: <p>This experimental paper studied repeated oral exposure to methyleugenol in mice and integrated toxicokinetics, liver metabolomics and gut microbiota changes. Repeated dosing produced dose-dependent rises in ALT/AST, liver histologic alterations, and metabolomic signatures consistent with disturbed TCA cycle and amino acid metabolism. Toxicokinetic data showed accumulation with repeated dosing and delayed Tmax, indicating potential for build-up. The authors conclude that methyleugenol can induce hepatocellular injury through metabolic activation and microbiota-linked pathways.</p> <p>Clinical implication: products or formulations of Piper cubeba enriched in methyleugenol (or other activated metabolites) should be used cautiously or avoided in people with severe liver disease because of possible additive liver injury.</p> </li> </ul> <h4> Known allergy to eugenol / isoeugenol / related fragrance compounds [Allergic contact or oral reactions]</h4> <ul> <li> ⚠️🤧 <li> Recommendation: If you have a documented contact allergy to eugenol, isoeugenol, or fragrance-mix sensitivity, do not use cubeb preparations that include eugenol/methyleugenol-rich oils (oral lozenges, pastes or direct oil exposures). <li> Reasoning: Many Piper species' volatile fractions include eugenol-type phenylpropanoids; eugenol is a known contact sensitizer and can provoke patch-test positivity and local allergic reactions even at low concentrations. <li> Scientific_Study_Title: Allergic reactivity for different dilutions of eugenol in repeated open application test and patch testing <li> Scientific_Study_Authors: Robert F. Ofenloch, Klaus Ejner Andersen, Caterina Foti, Ana Maria Giménez-Arnau, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37218587/ <li> Scientific_Study_Excerpt: <p>This multicenter clinical study evaluated patch testing and repeated open application tests (ROAT) with eugenol and found that individuals with contact allergy can react to very low concentrations; a majority of sensitized subjects produced positive responses on ROAT or patch testing. The report emphasizes that eugenol is a clinically relevant fragrance sensitizer and that elicitation thresholds can be low and persistent in sensitive people. The practical advice is to avoid topical or mucosal exposure to eugenol in sensitized patients to prevent dermatitis or mucosal inflammation.</p> <p>Implication for Sheetal Chini: preparations containing appreciable eugenol (or related compounds) may provoke contact or oral hypersensitivity in susceptible people and should be avoided.</p> </li> </ul> <h4> Use of concentrated cubeb essential oil / high-dose extract in young children or frail elderly [Formulation/dose-related contraindication]</h4> <ul> <li> 🚫👶👵 <li> Recommendation: Avoid essential-oil (undiluted) forms or high-dose standardized extracts in small children, infants and frail elderly; prefer low-dose traditional formulations or avoid entirely. <li> Reasoning: Cellular toxicology shows isolated lignans can be cytotoxic at higher concentrations; safety margins in vulnerable populations are narrow and pharmacokinetics differ in children/elderly. <li> Scientific_Study_Title: Evaluation of lignan (-)-cubebin extracted from Piper cubeba on human colon adenocarcinoma cells (HT29) <li> Scientific_Study_Authors: Andressa Megumi Niwa, Natalia Aparecida de Paula, Diogo Campos Vesenick, Daniele Sartori, Edson Luis Maistro, Lúcia Regina Ribeiro, Mário Sérgio Mantovani <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26817788/ <li> Scientific_Study_Excerpt: <p>Cell studies of the isolated lignan (-)-cubebin demonstrated that it is non-cytotoxic at low micromolar concentrations but becomes cytotoxic at higher (e.g., 280 µM) concentrations. The paper concludes that (-)-cubebin has a clear dose-dependent safety profile: safe at lower concentrations relevant to many formulations but potentially harmful if given in concentrated doses. This supports avoiding concentrated extracts or essential oil dosing in groups with altered metabolism or reduced reserve (young children, infants, frail elderly) who may accumulate active constituents or be more sensitive to cellular injury.</p> </li> </ul> <h3> Relative Contraindications of Sheetal Chini </h3> <h4> Concurrent use with antiplatelet / anticoagulant therapy [e.g., aspirin, clopidogrel, warfarin] </h4> <ul> <li> 🩸 <li> Recommendation: Use with caution - discuss with your prescribing clinician before taking Sheetal Chini if you are on blood thinners; closely monitor for bleeding signs. <li> Reasoning: Eugenol and related phenylpropanoids found in some cubeb oils inhibit platelet aggregation in human and animal studies, which could add to the effect of prescribed antithrombotics and raise bleeding risk. <li> Scientific_Study_Title: Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models <li> Scientific_Study_Authors: (study authors as listed on PubMed/PMC: authors of the Biomedicines / MDPI paper) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37517879/ (or PMC link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10888574/) <li> Scientific_Study_Excerpt: <p>Human platelet experiments and murine models reported that eugenol inhibited collagen- and arachidonic-acid induced platelet aggregation at low micromolar concentrations and reduced thrombus formation in animal models. Mechanistically, eugenol interfered with PLCγ2-PKC and cPLA2-TxA2 signalling axes and reduced thromboxane formation, which explains the anti-aggregatory effects. While the experiments were not clinical drug-interaction trials, the data indicate a biologically plausible additive antiplatelet effect when eugenol-rich preparations are combined with prescribed anticoagulants or antiplatelet drugs.</p> <p>Clinical implication: discuss with your doctor and consider monitoring clotting parameters or avoiding combined use when bleeding risk is high.</p> </li> </ul> <h4> Concurrent use with antidiabetic agents (insulin, sulfonylureas, metformin, alpha-glucosidase inhibitors)</h4> <ul> <li> 🍬⚖️ <li> Recommendation: If you are taking glucose-lowering medication, consult your physician before using Sheetal Chini regularly; blood glucose monitoring is advisable when starting or stopping the herb. <li> Reasoning: Extracts of Piper cubeba inhibit digestive enzymes (α-amylase and α-glucosidase) in vitro, which can modestly affect post-prandial glucose handling and theoretically alter effects of antidiabetic therapy. <li> Scientific_Study_Title: Cubeb (Piper cubeba L.f.): A comprehensive review of its botany, phytochemistry, traditional uses, and pharmacological properties <li> Scientific_Study_Authors: Drissi, Mahdi; Yassir; Ben Bakrim; Bouissane; Sobeh (Frontiers review) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/36483927/ <li> Scientific_Study_Excerpt: <p>Review articles summarise in vitro work where methanolic and aqueous extracts of P. cubeba inhibited α-glucosidase and α-amylase at experimentally tested concentrations, suggesting potential to reduce post-meal glucose spikes. The authors discuss that antioxidant and enzyme-inhibitory actions may contribute to traditional anti-diabetic uses, but emphasise most evidence is preclinical. For people on glucose-lowering medications, even modest additive effects may require dose adjustment or closer glucose monitoring.</p> </li> </ul> <h4> Breastfeeding / lactation [Use with caution]</h4> <ul> <li> 🤱 <li> Recommendation: Avoid concentrated cubeb essential oils and large-dose extracts while breastfeeding; for small traditional culinary or flavouring uses, discuss with a clinician if unsure. <li> Reasoning: Methyleugenol and some phenylpropanoids can form reactive metabolites and DNA adducts in humans; absence of human lactation safety data plus evidence of metabolic activation suggests a conservative approach. <li> Scientific_Study_Title: Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels <li> Scientific_Study_Authors: (as listed on PubMed: authors of the study; see PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28326452/ <li> Scientific_Study_Excerpt: <p>This human liver study demonstrated that methyleugenol forms DNA adducts in human liver tissue and that the amount of adduct correlated with SULT1A1 expression/genetic variation. The work confirms that methyleugenol undergoes bioactivation in humans to DNA-reactive metabolites; while this does not directly measure breast milk transfer, it supports a precautionary approach to high exposures in vulnerable populations, including nursing mothers and infants, until safety data are available.</p> </li> </ul>